在M2巨细胞和胃肠道 stromal 瘤的免疫治疗方面取得了进展
Xiao-Ke Wang1, Xin Yang1, Tong-Han Yao1
1The First School of Clinical Medical, Gansu University of Chinese Medicine, Lanzhou 730000, Gansu Province, China.
World journal of gastrointestinal oncology
|July 29, 2024
概括
胃肠道 stromal 瘤 (GIST) 免疫疗法显示出有希望的结果. 向M2巨细胞和PD-1/PD-L1通路可能会增强抗瘤免疫力,并改善GIST患者的治疗疗效.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 胃肠道 stromal 瘤 (GIST) 是消化道中最常见的介质细胞瘤.
- 伊马替尼布治疗改善了生存率,但存在局限性.
- M2巨细胞是GIST微环境的关键组成部分,促进瘤进展.
研究的目的:
- 审查M2巨细胞和GIST中的PD-1/PD-L1通路的作用.
- 探索增强GIST中抗瘤免疫力的策略.
- 为新的GIST免疫治疗方法提供见解.
主要方法:
- 关于GIST,M2巨细胞和免疫治疗的文献综述.
- 对编程死亡受体-1/编程死亡-1 (PD-1/PD-L1) 途径的分析.
- 探索M2巨细胞,PD-1/PD-L1和抗瘤免疫之间的相互作用.
主要成果:
- 在GIST中,M2巨细胞表现出瘤原生效应.
- PD-1/PD-L1通路与GIST微环境中的免疫逃避有关.
- 准M2巨细胞和PD-1/PD-L1可能会增强抗瘤反应.
结论:
- 调节M2巨细胞和PD-1/PD-L1通路为GIST免疫疗法提供了一个有前途的途径.
- 组合策略可以克服意马提尼布耐药性并改善患者的治疗结果.
- 对这些目标的进一步研究可能会导致更有效的GIST治疗.
关键词:
胃肠道 stromal 瘤是一种胃肠道瘤.伊马替尼布 (Imatinib) 的使用情况免疫治疗是一种免疫疗法.炎症反应是一种炎症反应.在M2巨细胞中.编程死亡联体-1 编程死亡联体-1编程死亡受体-1-1有针对性的治疗.更多相关视频
相关概念视频
Tumor Immunotherapy
498
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
498
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K


